Mizuho Maintains Outperform on Medtronic, Lowers Price Target to $120

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $125 to $120.